Translate

Thursday, October 12, 2017

thumbnail

CBIO Catalyst Biosciences, Inc. gains 46% Oct 12, 2017

Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders. http://www.priceseries.com/trade/CBIO-Catalyst-Biosciences-Inc--stock-gains-46-percent-a-Trade-Record-by-priceSeries-2017091220171012.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive